HIV Prevention

163 registered clinical trials studyying HIV Prevention — 47 currently recruiting.

Status	Trial	Sponsor	Phase
Not Yet Recruiting	A Social Network Approach to Improve HIV Prevention and Substance Use Treatment For People Who Use Drugs NCT07409350	NYU Langone Health	N/A
Not Yet Recruiting	Leveraging Video Logs as a Bridge to Pre-exposure Prophylaxis (PrEP) With Tailored Messaging to Black Women an NCT06864689	The University of Texas Medical Branch, Galveston	EARLY_Phase 1
Not Yet Recruiting	Private-sector Access to Testing for Health Sustainability NCT06820697	University of California, San Francisco	N/A
Not Yet Recruiting	PrEP & Soccer: A Program for Pharmacy Chains to Increase PrEP Awareness and Access Among Men NCT07263048	University of Miami	N/A
Not Yet Recruiting	Are Louisiana Pharmacists PrEPared? Implementing Training and an Active PrEP (Pre-Exposure Prophylaxis) Prescr NCT06530225	Xavier University of Louisiana.	—
Not Yet Recruiting	Mobile Vehicle-Based Delivery of Lenacapavir PrEP in Los Angeles County NCT07467018	University of California, Los Angeles	—
Not Yet Recruiting	RESTORE Study R61 Phase: Recovery and Engagement for Stimulant Users on Re-entry NCT07136363	University of Texas Southwestern Medical Center	N/A
Not Yet Recruiting	Evaluating an Interactive Digital Toolkit for Women's PrEP Implementation NCT07292584	University of Alabama at Birmingham	N/A
Not Yet Recruiting	Combatting HIV Or Other STIs Early (CHOOSE) in an RCT of mHealth Tool Support NCT07510048	Westat	Phase 2
Not Yet Recruiting	Leveraging Chatbot to Improve PrEP in the Southern United States NCT05968755	Yale University	N/A
Recruiting	HIV Self-testing for Partners of HIV-uninfected Postpartum Women NCT07194902	Massachusetts General Hospital	N/A
Recruiting	Using PrEP, Doing It for Ourselves NCT06638892	Duke University	N/A
Recruiting	PrOTECT AL: PrEP Optimization Through Enhanced Continuum Tracking NCT07231640	University of Alabama at Birmingham	N/A
Not Yet Recruiting	Pre-exposure Prophylaxis (PrEP) Adherence for Black MSM NCT06661343	Yale University	N/A
Recruiting	Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP NCT07218211	Duke University	Phase 4
Recruiting	Evaluation of Single Dosing With Two F/TAF Tablets Among Healthy Volunteers NCT07349758	Johns Hopkins University	Phase 1
Not Yet Recruiting	Initiative for Chinese Sex Workers to Promote Wellbeing and Improve HIV Prevention by Reducing intersEctional NCT07103525	NYU Langone Health	N/A
Recruiting	California MEPS Hub NCT07433985	University of California, Los Angeles	N/A
Recruiting	Suubi4PrEP: Improving PrEP Access and Adherence Among Adolescent Girls and Young Women in Uganda NCT07002866	Washington University School of Medicine	N/A
Enrolling By Invitation	The PROTECT (PrEP Optimization Through Telehealth Care and Treatment) Trial NCT06845774	Hilary L Surratt, PhD	N/A
Recruiting	Safe Spaces 4 Sexual Health NCT07133555	Johns Hopkins University	N/A
Not Yet Recruiting	Empowering Knowledge, Self-Testing & Resilience Through Innovative Methods for HIV NCT07039682	Universitas Sebelas Maret	N/A
Active Not Recruiting	Co-Developing an HIV Prevention Program for Women in Ghana NCT07003789	State University of New York at Buffalo	N/A
Active Not Recruiting	Evaluation of a Multi-Component Intervention to Support HIV Testing and Linkage to Services Among MSM in Peru NCT07074899	Fred Hutchinson Cancer Center	N/A
Recruiting	The Unlocking PrEP Study: Integration of Peer Health Navigation Into Comprehensive Re-entry Services NCT07292792	University of Texas Southwestern Medical Center	—
Recruiting	Prepping for The Talk: Helping Trusted Adults and Youth Talk About Sexual Health NCT07011563	Rhode Island Hospital	N/A
Enrolling By Invitation	Adaptive Intervention Strategies for HIV PrEP Care in Rural People Who Inject Drugs NCT06666309	Hilary L Surratt, PhD	N/A
Recruiting	Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons NCT07509853	Institute of HIV Research and Innovation Foundation, Thailand	N/A
Recruiting	Evaluation of a Differentiated Point-of-care Active Case Finding & Management Model to Eliminate Mother-to-Chi NCT06493357	University of North Carolina, Chapel Hill	N/A
Recruiting	Client-Centered Care Coordination for Black Men Who Have Sex With Men NCT06056544	University of Maryland, Baltimore	N/A
Recruiting	Behavioral Economic Intervention to Improve HIV Behaviors in Sexual Minority Individuals NCT06745947	The University of Texas Health Science Center at San Antonio	N/A
Recruiting	A Multi-Level Trauma-Informed Approach to Increase HIV Pre-exposure Prophylaxis Initiation Among Black Women NCT06703060	Johns Hopkins Bloomberg School of Public Health	N/A
Recruiting	Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: NCT07512869	Institute of HIV Research and Innovation Foundation, Thailand	—
Completed	Supporting Oral and Long-acting PrEP Decision Making Among Pregnant Women in Lilongwe, Malawi NCT06397690	University of North Carolina, Chapel Hill	N/A
Recruiting	WePrEP: Developing a PrEP Shared Decision-making Tool for Transgender Women NCT06656676	University of Colorado, Denver	N/A
Recruiting	Enhancing HIV Prevention and Reducing Alcohol Use Among People Receiving STI Care in Lilongwe, Malawi NCT06668363	University of North Carolina, Chapel Hill	N/A
Recruiting	Intervention to Enhance PrEP Persistence NCT06872307	Brown University	N/A
Recruiting	Leveraging Infant Visit PrEP INtegration & tasK Shifting to Improve Post-partum HIV Prevention in Malawi NCT06506188	University of North Carolina, Chapel Hill	N/A
Recruiting	Testing a Gender-inclusive HIV Prevention Program NCT06586151	Center for Innovative Public Health Research	N/A
Completed	Supporting Oral Pre-exposure Prophylaxis Decision Making Among Pregnant Women in Lilongwe, Malawi NCT06394323	University of North Carolina, Chapel Hill	N/A
Recruiting	Evaluation of mHealth Intervention to Promote HIV Prevention and Overcome Stigma Among Transgender Women (EMPO NCT07509827	Institute of HIV Research and Innovation Foundation, Thailand	N/A
Completed	Implantable Long-Acting Pre-Exposure Prophylaxis For MSM NCT05420207	Elizabeth Arnold	—
Active Not Recruiting	Post-Injectable Cabotegravir Antiretroviral Salvage Strategy Options Trial NCT06485154	University of Witwatersrand, South Africa	Phase 4
Recruiting	Pre-implementation Study to Develop Trans-tailored Services for Transgender Persons in Relation to chemsEX NCT07505875	Institute of HIV Research and Innovation Foundation, Thailand	—
Recruiting	UNCPM 22314 - Pregnancy, Infant and Maternal Health Outcomes Study NCT06158126	University of North Carolina, Chapel Hill	Phase 4
Unknown	Pharmacy-based PrEP for Young Women Who Sell Sex in Zimbabwe NCT06348069	University of California, Berkeley	N/A
Completed	Social Media as a Risk Tool for HIV Prevention Needs NCT06566417	Massachusetts General Hospital	—
Recruiting	The Implementation of a Trans-tailored Harm Reduction Service for Transgender Persons in Relation to chemsEX a NCT07512856	Institute of HIV Research and Innovation Foundation, Thailand	N/A
Recruiting	An Acceptance Based PrEP Intervention to Engage Young Black MSM in the South NCT05087680	Rhode Island Hospital	N/A
Recruiting	Optimizing Pre-Exposure Prophylaxis (PrEP) Among Latino Men Who Have Sex With Men (MSM) in Puerto Rico NCT05804461	University of Puerto Rico	N/A
Unknown	PrEP Restart for Adolescent Girls and Young Women Using STI Self Testing and Assessment of Risk NCT06030856	Wits RHI Research Centre Clinical Research Site	N/A
Terminated	A Pharmacist-run PrEP Program for Women NCT05755204	Orlando Immunology Center	—
Terminated	The CATALYST Study NCT05937698	FHI 360	—
Terminated	Eswatini Ring Study: Increasing PrEP Options for Women NCT05889533	FHI 360	—
Completed	Study for IFE4PrEP Intervention on PrEP Uptake by Southern African American Women NCT05087927	University of North Carolina, Chapel Hill	—
Completed	Pilot Mobile Medical Unit Study for I'm Fully Empowered4Her NCT05644834	University of North Carolina, Chapel Hill	N/A
Unknown	PrEPared-RN, CAN Nurse-Led Management of High-risk Patients for Pre-Exposure Prophylaxis (PrEP) NCT06030557	CAN Community Health	—
Unknown	Express Testing and Same-day Initiation of PrEP Study NCT05690815	HQ Toronto	—
Active Not Recruiting	Clinic-based HIV Identification and Prevention Project Using Electronic Resources NCT05412433	Johns Hopkins University	N/A
Completed	Telehealth as a Modality to Increase the Uptake of PrEP Services in Black and Latino: "e-PrEP" NCT05528653	Vivent Health	Phase 4
Unknown	A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM a NCT05474313	Public Health Foundation Enterprises, Inc.	N/A
Recruiting	Hybrid Evaluation of a Home-based HIV Pre-exposure Prophylaxis Program NCT05856942	University of Washington	N/A
Completed	TAKE Steps: Motivational Interviewing to Prevent STIs NCT05215262	Children's Hospital of Philadelphia	N/A
Completed	Peer PrEP Referral + HIV Self-test Delivery for PrEP Initiation in Kenya NCT04982250	Fred Hutchinson Cancer Center	N/A
Completed	Podcasting HIV Prevention Within African American Communities NCT05365958	University of Houston	N/A
Active Not Recruiting	PrEP Affect Regulation Treatment Innovation NCT04899024	Florida International University	N/A
Completed	Randomized Controlled Trial of Game Changers NCT05098015	RAND	N/A
Active Not Recruiting	Digital Limited Interaction Efficacy Trial of LifeSkills Mobile to Reduce HIV Incidence in YTW NCT05018611	University of California, Los Angeles	N/A
Recruiting	Stick2PrEP Cisgender Women and Trans Individuals NCT05165745	Columbia University	N/A
Completed	Addressing Health Disparities in Engagement, Retention, and Utilization of PrEP Among South Florida Women of C NCT05338996	Florida International University	N/A
Completed	Integrated PrEP Interventions for People Who Inject Drugs in Rural Kentucky NCT05037513	Hilary L Surratt, PhD	N/A
Completed	Evaluating Distribution of a Tenofovir Douche With Tap Water Douching and Simulated Receptive Anal Intercourse NCT04195776	Johns Hopkins University	Phase 1
Recruiting	HIV Outpatient Monitoring Evaluation Through Self-collection of Dried Blood Spots NCT04979728	University of Colorado, Denver	—
Completed	The Shauriana Intervention for GBMSM in Kenya NCT04550221	University of Washington	N/A
Completed	Tenofovir Rectal Douche to Prevent HIV Transmission Among Adolescents (ATN DREAM) NCT04686279	University of Pennsylvania	Phase 1
Completed	Pre-Exposure Prophylaxis for Transgender Women in the US and South America NCT04742491	HIV Prevention Trials Network	Phase 2 / Phase 3
Completed	Reducing Intersectional Stigma Among High-Risk Women in Brazil to Promote Uptake of HIV Testing and PrEP NCT04114955	University of California, San Francisco	N/A
Completed	Pharmacy Delivery to Expand the Reach of PrEP in Kenya NCT04558554	University of Washington	N/A
Terminated	Long-acting Biomedical HIV Prevention in Transgender Women NCT03856580	University of Colorado, Denver	N/A
Completed	Feminizing Hormone Therapy and the Rectal Mucosa Immune Environment in Transgender Women NCT04531943	Emory University	—
Completed	Streamlining the Efficiency of PrEP Implementation NCT04424524	University of Washington	N/A
Completed	Isisekelo Sempilo Trial to Optimize Peer (Thetha Nami) Delivery of HIV Prevention to Young People in Rural Kwa NCT04532307	Africa Health Research Institute	N/A
Completed	Couple User Preferences in Dual Purpose Prevention Products NCT04023799	Microbicide Trials Network	—
Completed	Tenofovir Rectal Douche to Prevent HIV Transmission NCT04016233	Johns Hopkins University	Phase 1
Active Not Recruiting	Integrated HIV Prevention and HCV Care for PWID NCT03981445	Columbia University	N/A
Completed	OB-002H Gel Administered Vaginally and Rectally in HIV-1 Seronegative Adults NCT04791007	Orion Biotechnology Polska Sp. z o.o.	EARLY_Phase 1
Terminated	Griffithsin-based Rectal Microbicide for PREvention of Viral ENTry (PREVENT) NCT04032717	Rhonda Brand	Phase 1
Completed	Optimizing PrEP Utilization Among Alcohol and Other Drug (AOD) Using Women of Color NCT04018651	Florida International University	N/A
Completed	Rectal Microbicide Acceptability, Tolerability and Adherence NCT03671239	Microbicide Trials Network	N/A
Completed	The PrEPARE Project: Prevention, Empowering, and Protecting Young Women in South Africa NCT04048551	RTI International	N/A
Completed	A Functional Performance Study of The Wondaleaf Female Condom NCT04076774	Prof Mags Beksinska	N/A
Completed	DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men NCT03771638	Public Health Foundation Enterprises, Inc.	Phase 4
Unknown	The BeT Study Intervention to Reduce Disparities in HIV Prevention and Care NCT05299645	Evandro Chagas National Institute of Infectious Disease	N/A
Completed	Biktarvy for Non-Occupational Post-Exposure Prophylaxis (nPEP) NCT03499483	Fenway Community Health	Phase 4
Completed	Using Smart Phone Technology to Support PrEP Uptake and Adherence NCT04868383	University of Virginia	N/A
Recruiting	Dat'Aids Prevention NCT03795376	DatAids	—
Terminated	Scalable Interventions to Increase PrEP Adherence: Value Affirmation and Future Selves NCT03278990	Stuart Fisk	N/A
Completed	Acceptability and Performance of HIV Self-Testing in a Youth Population in Nigeria NCT03874663	Washington University School of Medicine	—
Completed	An Accessible Digital Intervention to Promote HIV Testing/Counseling and Prevention Among Adolescents NCT03713034	Yale University	N/A
Completed	The Community PrEP Study to Assess the Acceptance of PrEP Delivered Through CBCT Platforms NCT03977181	Foundation for Professional Development (Pty) Ltd	N/A
Completed	Single Dose Truvada Study NCT03719053	Johns Hopkins University	Phase 1
Unknown	PrEP-Pod-IVR (TDF-FTC/Placebo IVR 28 Day Crossover Study) NCT03255915	Oak Crest Institute of Science	EARLY_Phase 1
Unknown	HIV Self-testing in Implementation PrEP Study NCT03642314	Oswaldo Cruz Foundation	N/A
Completed	Microbicide/PrEP Acceptability Among Mothers and Male Partners in Africa NCT03648931	Microbicide Trials Network	—
Completed	ATN 151 Work-to-Prevent: Employment as HIV Prevention NCT03313310	University of North Carolina, Chapel Hill	N/A
Completed	Integrated BA and HIV RR Counseling for MSM With Stimulant Abuse NCT03175159	University of California, Los Angeles	N/A
Completed	Youth-focused Strategies to Promote Adherence to Pre-exposure Prophylaxis Among Youth At-risk for HIV in Thail NCT03778892	Chulalongkorn University	N/A
Completed	DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence NCT03387462	Public Health Foundation Enterprises, Inc.	Phase 4
Completed	A Pharmacokinetic Evaluation of Tenofovir/Emtricitabine as HIV Pre-Exposure Prophylaxis in Transgender Women NCT03270969	University of Nebraska	Phase 1
Completed	Periconception PrEP for HIV-exposed Ugandan Women NCT03832530	Massachusetts General Hospital	N/A
Completed	Western Australian Pre-exposure Prophylaxis for HIV Implementation Trial NCT03327155	Kirby Institute	Phase 3
Completed	Safer Conception for Women - Understanding Use of Periconception PrEP NCT03194308	Massachusetts General Hospital	Phase 4
Completed	ImQuest (IQP) DuoGel Phase 1 Pharmacokinetic Study NCT03082690	Johns Hopkins University	Phase 1
Completed	Project WERK (Wellness Encouragement Respect Kinship) NCT03148171	University of Chicago	N/A
Completed	Preventing HIV Among Native Americans Through the Treatment PTSD & Substance Use NCT03112369	University of Washington	N/A
Completed	Study of Truvada for HIV Pre Exposure Prophylaxis Using Daily Directly Observed Therapy to Look at Potential I NCT04050371	University of California, San Francisco	Phase 4
Unknown	Implementation of PrEP to HIV in Brazilian Transgender Women NCT03220152	Oswaldo Cruz Foundation	Phase 4
Completed	Social Media Based Peer-Led Intervention for HIV Prevention NCT03213366	Montefiore Medical Center	N/A
Completed	PK and Safety Study of Vaginal Rings Containing Dapivirine and Levonorgestrel NCT02855346	International Partnership for Microbicides, Inc.	Phase 1
Completed	Safety and Acceptability Study of PrePex Device When Removing the Foreskin Shortly After Placement of Device NCT03132285	Ministry of Health, Zambia	N/A
Completed	VRC 605: Safety and Pharmacokinetics of a Human Monoclonal Antibody, VRC-HIVMAB075-00-AB (VRC07-523LS), Admini NCT03015181	National Institute of Allergy and Infectious Diseases (NIAID)	Phase 1
Unknown	Demonstration Project on the Feasibility to Implement PrEP in MSM and TG Women NCT03043326	Asociación Civil Impacta Salud y Educación, Peru	—
Completed	HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing NCT03138135	Public Health Foundation Enterprises, Inc.	N/A
Unknown	Digital Health Feedback System (DHFS) for Longitudinal Monitoring of ARVs Used in HIV Pre-exposure Prophylaxis NCT03693040	University of California, San Diego	N/A
Completed	Optimization of a Tenofovir Enema for HIV Prevention NCT02750540	Johns Hopkins University	Phase 1
Completed	To Assess Continued Safety of and Adherence to the Dapivirine (25 mg) Vaginal Ring-004 in Healthy, HIV-negativ NCT02862171	International Partnership for Microbicides, Inc.	Phase 3
Completed	Assessment of ASPIRE and HOPE Adherence NCT02702895	Microbicide Trials Network	—
Completed	STI Care Model to Reduce Genital Inflammation and HIV Risk in South African Women NCT03407586	Centre for the AIDS Programme of Research in South Africa	N/A
Completed	Pre-exposure Prophylaxis (PrEP) Adherence Enhancement Guided by iTAB and Drug Levels for Women NCT02584140	University of California, Los Angeles	Phase 4
Completed	Finding the Right Tenofovir/Emtricitabine Regimen for Pre-Exposure Prophylaxis (PrEP) in Transgender Women NCT03060785	Johns Hopkins University	Phase 1
Completed	Helping Men Have Healthy Babies NCT03818984	Massachusetts General Hospital	N/A
Completed	To Assess the Drug-drug Interaction Potential Between Dapivirine Vaginal Ring-004, Containing 25 mg of Dapivir NCT02847286	International Partnership for Microbicides, Inc.	Phase 1
Enrolling By Invitation	Evaluation of PrEP-30: a Demonstration Project of Pre-exposure Prophylaxis for MSM and Other High-risk Group C NCT02437981	Thai Red Cross AIDS Research Centre	—
Completed	Tenofovir Levels Following Local Application of Tenofovir Reduced-Glycerin 1% Gel NCT01768962	CONRAD	Phase 1
Completed	In Vivo Drug Interaction Pharmacokinetic Study of Tenofovir 1% Gel and Three Commonly Used Vaginal Products NCT01813162	CONRAD	Phase 1
Completed	Influence of Reproductive Cycle and Menopause on HIV-1 Infection and TFV Gel Activity NCT01810315	CONRAD	Phase 1
Completed	SEPA III: The Effectiveness Trial NCT02405481	University of Miami	N/A
Completed	A Demonstration Project to Add Pre- or Post-exposure Prophylaxis to Combination HIV Prevention Services NCT01781806	University of California, Los Angeles	Phase 4
Completed	Biomarkers of Protocol Compliance and Product Adherence NCT01804023	CONRAD	—
Completed	A Study to Compare Three Different Formulations of Tenofovir 1% Gel When Administered Rectally NCT01575405	Ian McGowan	Phase 1
Completed	An Exploratory Rectal Safety Study of Three Tenofovir Gel Formulations NCT01575418	Ian McGowan	Phase 1
Completed	Formative Research for an HIV Videogame for Young Black Women NCT02685410	Yale University	N/A
Completed	An Exploratory Study of Potential Sources of Efficacy Dilution in the VOICE Trial (MTN-003) NCT02358616	Microbicide Trials Network	—
Completed	An Integrated HIV Prevention Model for African American Mothers and Daughters NCT02958813	University of Illinois at Chicago	N/A
Completed	Follow Up Study to Evaluate a Non-Surgical Device for Adult Male Circumcision for Screen Failure Subjects NCT02281435	Ministry of Health, Rwanda	N/A
Unknown	Couples in Context: An RCT of a Couples-based HIV Prevention Intervention NCT01953133	University of California, San Francisco	N/A
Completed	Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal NCT01421368	CONRAD	Phase 1
Completed	Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection NCT01386294	CONRAD	Phase 3
Completed	Integrated Mental Health Treatment & HIV Prevention for Court-Involved Youth NCT01421485	Rhode Island Hospital	N/A
Completed	Cohort Field Study to Assess the Safety and Efficacy of the PrePex Device for Non-Surgical Circumcision When P NCT01434628	Ministry of Health, Rwanda	N/A
Completed	Four-Arm Randomized Control Trial of Brief MI Versus Couples-Based HIV/STI Prevention in South Africa NCT01554423	The City College of New York	N/A
Completed	Raltegravir Use as Nonoccupational Postexposure Prophylaxis (NPEP) in Men Who Have Sex With Men NCT01087840	Andrew Carr	Phase 4
Completed	A Pivotal Study to Assess the Safety and Efficacy of The PrePex System, a Male Circumcision Device and Methodo NCT01150370	Ministry of Health, Rwanda	N/A
Completed	Interventions for HIV Negative Men and Women Who Have High-risk Suspected Exposure to HIV NCT00949234	University of California, Los Angeles	Phase 2
Completed	The Shang Ring: A Novel Male Circumcision Device for HIV Prevention NCT00993811	Weill Medical College of Cornell University	Phase 1
Completed	Rectal Microbicide Safety and Acceptability Trial of Topically Applied Tenofovir Compared With Oral Tablet NCT00984971	CONRAD	Phase 1
Completed	Development and Testing of a Jamaican Mother-daughter HIV Risk-reduction Program NCT03411577	Boston College	N/A
Completed	HIV- Risk Reduction Behavioral Intervention for Commercial Sex Workers in Yerevan Armenia NCT00886561	Emory University	Phase 2
Completed	Effectiveness of Opiate Replacement Therapy Administered Prior to Release From a Correctional Facility - 1 NCT00142935	The Miriam Hospital	N/A
Completed	Adopting and Demonstrating the Adaptation of Prevention Techniques: Community PROMISE PLUS NCT00267436	Centers for Disease Control and Prevention	Phase 1 / Phase 2
Completed	S.T.A.R.S.: Sistas Talking About Real Solutions NCT01028157	Emory University	Phase 1
Withdrawn	Safety and Acceptability of Tenofovir 1% Gel in Adolescent Females NCT02245945	CONRAD	Phase 1
Withdrawn	Paper Applicator Acceptability Study NCT02179138	CONRAD	Phase 1 / Phase 2